The Science of Peptides, Decoded
Evidence-based answers on peptides, DNA & biohacking — synthesized from 4,000+ books, peer-reviewed journals, and Nobel-laureate research. No products. No hype. Just what the evidence actually shows.
Latest research
- What is the actual storage, reconstitution, and handling discipline that distinguishes practitioner-grade peptide use from at-home use — and how much potency is lost when users fail at it?
- For psoriasis, which integrative practitioners have moved away from peptides entirely after seeing real outcomes vs. biologics, and what was their reasoning?
- What do top retatrutide prescribers do when patients hit the appetite-suppression plateau around month 4 that public protocols don’t address?
- In alopecia practice, what combination protocols (minoxidil + finasteride + GHK-Cu + microneedling + low-dose PDE5) do the top trichology clinics actually use, and what is the marginal contribution of the peptide component?
- What separates a top compounding pharmacist’s peptide preparation from a research-chemical supplier’s — and how would a sophisticated buyer in Romania verify those differences without a lab?
- What does an experienced cosmetic chemist do differently when formulating a GHK-Cu serum that will actually deliver intact peptide to keratinocytes, vs. what shows up on the INCI label of typical EU-market products?
- Which peptides do experienced practitioners quietly avoid in their own personal use, and what do their reasons reveal about the risk/benefit calculation that’s missing from patient-facing material?
- Among elite-athlete physicians who use peptides off-label, what is the actual injection protocol (site, frequency, micro-dose, time-of-day) for BPC-157 in tendon injury — and how does it differ from forum dogma?
- What is the unwritten heuristic top practitioners use to decide when to stop a peptide that “should” be working, and how does that compare to manufacturer-recommended cycle lengths?
